Tryp Therapeutics: Unlocking the potential of psychedelic medicine
Connect with us

CSE: TRYP   |   OTCQB: TRYPF

Twitter Linkedin-in Envelope Link

The New Era of Psychedelic Medicine

September 22, 2021
Tryp Therapeutics submits IND Application for Phase 2A Clinical Trail in eating disorders
September 1, 2021
Tryp Therapeutics to present at H.C. Wainwright Global Investment Conference
August 24, 2021
Tryp Therapeutics completes Psychotherapy Training for Phase 2A study University of Florida
By clicking “submit”, I agree to be contacted by Tryp Therapeutics and understand that I may opt-out at any time.

View Privacy Policy

More from Tryp Therapeutics

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp